Fritextsökning
Innehållstyper
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
S: injicera statligt riskkapital
-Vi vill ge marknaden en ordentlig injektion i form av en statlig riskkapitalfond. Vi vill även införa ett särskilt riskkapitalavdrag för dem som investerar i mindre bolag.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
Genombrott för patentlagar i USA
Nu blir det lättare för europeiska företag att söka patent i USA.
-
Partnering offer for scientists and medics
For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I
-
Genombrott för patentlagar i USA
Nu blir det lättare för europeiska företag att söka patent i USA.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Almi Invest vill ta in fler life science-företag
Det statliga riskkapitalbolaget Almi Invest har startat en kampanj för att få fler företag inom life science-sektorn att söka sig till dem.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
75 million for research schools
Gothenburg University, Karolinska Institutet, Linköping University and Umeå University have received SEK 75 million from the Research Council. The money will be...
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Sofia Nilsson (C): ”Life science-strategin behöver tydligare prioriteringar”
Centerpartiet vill inrätta ett tioårigt forskningsprogram om sjukdomar som drabbar kvinnor. Det berättar Sofia Nilsson (C), i Life Science Swedens intervjuserie...
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Så funkar det på molekylär nivå
Forskare vid bl a kemiska institutionen, Umeå universitet, har lyckats simulera hur kolhydrater tas upp från cellens utsida av transportproteinet LacY.
-
Kebnekaise invigs - I Umeå
Nu invigs den nya superdatorn Kebnekaise.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Infektion kan göra håret grått
Ny studie visar på varför svår sjukdom och stress som leder till inflammation kan förändra hårfärgen.
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
BREAKING